Big Gain For Adamis Pharmaceuticals Corporation
Thu, Aug 17, 2023 at 07:13 PM
Adamis Pharmaceuticals Corporation (ADMP:NASDAQ) soared at $1.02, representing a gain of 28.6%. On Thu, Aug 17, 2023, ADMP:NASDAQ hit a New 2-Week Intraday Low of $0.78. The stock appeared on our News Catalysts scanner on Fri, Aug 04, 2023 at 04:28 PM in the 'PUBLIC OFFERING' category. From Thu, Aug 03, 2023, the stock recorded 10.00% Up Days and 27.27% Green Days
The stock spiked on Tue, Aug 01, 2023 at $8.28 with a volume of 20M+.
About Adamis Pharmaceuticals Corporation (ADMP:NASDAQ)
Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company that develops & commercializes products in the therapeutic areas of respiratory disease & allergy. Its products include Epinephrine Injection PFS syringe, APC-1000, APC-2000, & APC-5000.
Top 10 Gainers:
- Unico American Corporation (UNAM:NASDAQ), 566.67%
- PhenomeX Inc Com (CELL:NASDAQ), 136.25%
- Trio Petroleum Corp. (TPET:NYSEMKT), 51.5%
- Oncorus Inc. (ONCR:NASDAQ), 41.85%
- SatixFy Communications Ltd. (SATX:NYSEMKT), 35.99%
- Aditxt Inc. (ADTX:NASDAQ), 32.72%
- Hanryu Holdings, Inc. (HRYU:NASDAQ), 31.59%
- SRAX, Inc. (SRAX:NASDAQ), 31.47%
- Adamis Pharmaceuticals Corporation (ADMP:NASDAQ), 28.56%
- Faraday Future Intelligent Electric Inc. (FFIE:NASDAQ), 25.57%